Impact of Endothelial and Leukocyte Senescence in Circulatory Shock States
University Hospital, Strasbourg, France
520 participants
Jan 7, 2019
OBSERVATIONAL
Conditions
Summary
Circulatory shocks (CS) are life-threatening, acute organ dysfunction. Advances in critical care medicine have decreased early hospital mortality, increasing the number of surviving patients. Regrettably, these survivors are at increased risk of new infections but also of cardiovascular disease. The investigators hypothesize that CS with multi-organ dysfunction is associated with premature senescence of endothelial cells and immune cells and promotes endothelial thrombogenicity and immunosenescence leading to cardiovascular disease and secondary infections. The aim of this work is therefore to evaluate the contribution of endothelial and leucocytes senescence to the occurrence of secondary events (infectious and cardiovascular) in patients with a CS. It will provide a better understanding of the pathogenesis of cardiovascular and immune diseases following a CS, likely to guide new management strategies to prevent their occurrence.
Eligibility
Inclusion Criteria2
- Circulatory shock
- patient with health care insurance
Exclusion Criteria4
- Patients' refusal to participate in clinical research
- Pregnant woman
- Breastfeeding woman
- A patient with a protective order
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Noninvasive, reproducible, and sensitive methods to measure cardiac function, endothelial function, and arterial stiffness will be assess.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03559569